Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
Ana Hoxha, Steven M. Kerr, Henry Laurenson‐Schafer, Nikola Sklenovská, Bernadette Basuta Mirembe, Ingrid Hammermeister Nezu, Patricia Ndumbi, Julia Fitzner, María Almirón, Marcelo Vila, Richard Pebody, Aisling Vaughan, Joana M. Haussig, Luís Alves de Sousa, Okot Charles Lukoya, Olaniyi Felix Sanni, Pierre Nabeth, Jeremias Naiene, Masaya Kato, Tamano Matsui, Krutika Kuppalli, Peter Mala, Rosamund Lewis, Olivier le Polain de Waroux, Boris Pavlin, WHO Mpox surveillance and Analytics Team
Abstract
The 2022-2023 mpox outbreak predominantly affected adult men; 1.3% of reported cases were in children and adolescents <18 years of age. Analysis of global surveillance data showed 1 hospital intensive care unit admission and 0 deaths in that age group. Transmission routes and clinical manifestations varied across age subgroups.